Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Preveceutical Medical Inc
PRVCF
Primary Symbol:
C.PREV
PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based...
nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:PREV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(235)
•••
geodcan
X
View Profile
View Bullboard History
Comment by
geodcan
on May 06, 2024 5:16pm
RE:BCSC dismisses case against Preveceutical Medical
Bullchit moves by everybody involved and a huge black eye for securities watchdogs who cratered to management and not investors. My guess is that the other half of the raise went to buy votes to come
...more
(22)
•••
KidAtHeart
X
View Profile
View Bullboard History
Post by
KidAtHeart
on May 03, 2024 10:41am
BCSC dismisses case against Preveceutical Medical
BCSC dismisses case against Preveceutical Medical 2024-05-02 20:59 ET - Street Wire Also Street Wire (C-PREV) Preveceutical Medical Inc by Mike Caswell The B.C. Securities
...more
(24)
•••
bveilleu
X
View Profile
View Bullboard History
Comment by
bveilleu
on May 03, 2024 10:16am
RE:What's going on today
PreveCeutical Announces Management Cease Trade Order Vancouver, British Columbia--(Newsfile Corp. - May 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the
...more
(1)
•••
den1731
X
View Profile
View Bullboard History
Post by
den1731
on May 03, 2024 9:57am
What's going on today
High volumn drops 33.3% to 0.015, but can't find any news
(1)
•••
den1731
X
View Profile
View Bullboard History
Post by
den1731
on Mar 14, 2024 4:43pm
Still nothing happened
Volume was up the whole week, but sp still stay in 0.02
(135)
•••
Walter333
X
View Profile
View Bullboard History
Post by
Walter333
on Jan 08, 2024 6:26am
Shaping up to be quite the year of M&A activity
[url=https://https://www.cnbc.com/2024/01/05/cramer-names-biopharma-companies-as-industry-mergers-start-to-accrue.html]news on M&A activity[/url]
(235)
•••
geodcan
X
View Profile
View Bullboard History
Comment by
geodcan
on Dec 31, 2023 8:45pm
RE:Something happening!
Wrong board! oopsed!
(235)
•••
geodcan
X
View Profile
View Bullboard History
Post by
geodcan
on Dec 31, 2023 8:44pm
Something happening!
OTCPK:BMKDF | Insider Transactions | BioMark Diagnostics Inc (stockhouse.com)
(135)
•••
Walter333
X
View Profile
View Bullboard History
Post by
Walter333
on Dec 13, 2023 2:24pm
Tic tock tic tock
https://www.cnbc.com/2023/12/13/fed-interest-rate-decision-december-2023.html
(135)
•••
Walter333
X
View Profile
View Bullboard History
Post by
Walter333
on Dec 13, 2023 11:13am
Potential upcoming catalysts
Endosane payment(s) related to sol gel. Secure funding Partnership announcement Commencement of trials
(135)
•••
Walter333
X
View Profile
View Bullboard History
Post by
Walter333
on Dec 10, 2023 9:10am
Interest from world leading pharma in PREV dual gene therapy
https://www.prnewswire.com/news-releases/preveceutical-initiates-preparation-of-proof-of-concept-preclinical-study-for-its-diabetes--obesity-dual-gene-therapy-program-302003747.html
(24)
•••
shaker13
X
View Profile
View Bullboard History
Comment by
shaker13
on Sep 12, 2023 8:26am
RE:Prime time
If PREV really wanted to be taken serious about getting on the AI Bandwagon, they should be smart enough to stay away from OpenAI ChatGPT This AI Hallucinates , is full of Biases and spits out
...more
(135)
•••
Walter333
X
View Profile
View Bullboard History
Post by
Walter333
on Sep 01, 2023 2:27pm
Prime time
National news here we come, the time for Preveceutical to shine has arrived! Good luck all.
(135)
•••
Walter333
X
View Profile
View Bullboard History
Post by
Walter333
on Apr 01, 2023 10:27pm
Progress
Nice headway being made here. If POC is verified through trials then Prev just may become a buyout or partnership candidate with real tangible value.
(1)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Mar 20, 2023 10:04am
PreveCeutical Initiates Non-Analgesic (Painkiller) Program
Vancouver, British Columbia--(Newsfile Corp. - March 20, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario